View Pages
ARK September Market Update: Tesla Cybercab, AI Risks, and Cancer Breakthrough
Cathie Wood reviews yield-curve signals, AI extinction debate, agentic products, inference speed, Tesla Cybercab economics, new ARK Venture names, and the first individualized cancer vaccine clearing Phase 3.
Editorial companion
What stands out
Cathie Wood’s September update stitches together three big threads: Tesla’s Cybercab economics, a renewed wave of agentic AI products and inference-speed premiums, and an individualized cancer vaccine clearing Phase 3. Those are not bite-sized headlines; they are signals about where capital and talent may flow for a decade. For investors watching Tesla, and even industrial names that ride macro cycles, ARK’s framing forces a choice between betting on structural disruption or protecting against near-term earnings stress.
View Pages
Bullish Gator Snapshot
Current ratings and signals
Archer Daniels Midland (ADM)
Bearish
ADM rates Bearish overall. The fundamental read is neutral: the company passes 5 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 3.19); revenue is declining about 7.5% per year; net income is declining about 36.0% per year. The technical picture is bearish: price is 3.3% above the 200-day moving average; 4.8% below the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bearish (composite 30/100), based on 4 news articles from recent coverage.
Tesla, Inc. (TSLA)
Bullish
TSLA rates Bullish overall. The fundamental read is bullish: the company passes 5 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 19.10); revenue is growing about 5.6% per year; net income is declining about 26.6% per year. The technical picture is bullish: price is 5.6% above the 200-day moving average; 11.3% above the 50-day; the 50/200 relationship is in a Death cross. Sentiment is bullish (composite 73/100), based on 8 news articles, 8 TV segments, and 6 qualified videos from recent coverage.